Healthy volunteer study tests two injection methods for sonelokimab
Knowledge-focused
Completed
This study checked if giving sonelokimab with a prefilled syringe or an autoinjector leads to the same drug levels in the body. It involved 120 healthy adults aged 18–55. The goal was to confirm the two devices are equivalent, not to treat any disease.
Phase: PHASE1 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Knowledge-focused
Last updated May 26, 2026 11:09 UTC